Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 1997

View Archived Issues

Allergan: Q3 1997 highlights

Incyte: Q3 1997 highlights

Theratechnologies: Q3 1997 highlights

Labopharm: HY1997 highlights

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

ARS discloses new 5alpha-reductase inhibitors

Researchers at Janssen/Neurocrine Biosciences develop CRF antagonists

Histamine H3 ligands prepared by James Black Foundation

P&U describes new ergoline derivatives for CNS disorders

Spotlight on smoking cessation therapy

New preclinical data presented on ACEA-1021

SA-4503 offered for licensing by Santen

TOP-53: preclinical antitumor activity and pharmacokinetics

Watson acquires Searle contraceptive products

SciClone presents promising preclinical data for CPX at CF conference

Janssen, Gliatech extend Alzheimer's disease research agreement

Mechanism of action elucidated for anthracycline developed by Sumitomo

Topical antiinflammatory activity of COX-2 inhibitors assessed

Low-molecular-weight selectin inhibitor displays potent antiinflammatory activity

Promising preliminary results reported from pertussis vaccine project

Antiangiogenic agent TNP-470 suppresses tumorigenesis in animal model

Possible MDR-modulating effect described for E-6123, a PAF antagonist

Apoptotic effects described for antiestrogen

Flamel Technologies reports clinical results on Asacard

IL-15 exerts potent antiapoptotic effects in vivo

VIMRxyn enters phase II for treatment of skin diseases

SuperGen files supplemental NDA for Nipent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...